Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua W Henshaw

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|July 13, 2007
Field distribution and DNA transport in solid tumors during electric field-mediated gene deliveryJoshua W Henshaw, Fan Yuan
Experimental Biology and Medicine (Maywood, N.J.)|December 25, 2007
Mechanistic analysis of electroporation-induced cellular uptake of macromoleculesDavid A Zaharoff, Joshua W Henshaw, Brian Mossop, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|May 23, 2006
A single molecule detection method for understanding mechanisms of electric field-mediated interstitial transport of genesJoshua W Henshaw, David A Zaharoff, Brian J Mossop, et al.
Annals of Biomedical Engineering|March 7, 2007
Electric fields around and within single cells during electroporation-a model studyBrian J Mossop, Roger C Barr, Joshua W Henshaw, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|August 31, 2007
Electric field-mediated transport of plasmid DNA in tumor interstitium in vivoJoshua W Henshaw, David A Zaharoff, Brian J Mossop, et al.
Annals of Biomedical Engineering|August 19, 2006
Electric fields in tumors exposed to external voltage sources: implication for electric field-mediated drug and gene deliveryBrian J Mossop, Roger C Barr, Joshua W Henshaw, et al.
Clinical and Translational Science|June 2, 2021
Dose selection for intracerebroventricular cerliponase alfa in children with CLN2 disease, translation from animal to human in a rare genetic diseaseKevin Hammon, Greg de Hart, Brian R Vuillemenot, et al.
Clinical and Translational Science|November 17, 2020
Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular AdministrationAryun Kim, Anita Grover, Kevin Hammon, et al.
Cancer Discovery|March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic CancersJohann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|July 13, 2007
Field distribution and DNA transport in solid tumors during electric field-mediated gene deliveryJoshua W Henshaw, Fan Yuan
Experimental Biology and Medicine (Maywood, N.J.)|December 25, 2007
Mechanistic analysis of electroporation-induced cellular uptake of macromoleculesDavid A Zaharoff, Joshua W Henshaw, Brian Mossop, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|May 23, 2006
A single molecule detection method for understanding mechanisms of electric field-mediated interstitial transport of genesJoshua W Henshaw, David A Zaharoff, Brian J Mossop, et al.
Annals of Biomedical Engineering|March 7, 2007
Electric fields around and within single cells during electroporation-a model studyBrian J Mossop, Roger C Barr, Joshua W Henshaw, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|August 31, 2007
Electric field-mediated transport of plasmid DNA in tumor interstitium in vivoJoshua W Henshaw, David A Zaharoff, Brian J Mossop, et al.
Annals of Biomedical Engineering|August 19, 2006
Electric fields in tumors exposed to external voltage sources: implication for electric field-mediated drug and gene deliveryBrian J Mossop, Roger C Barr, Joshua W Henshaw, et al.
Clinical and Translational Science|June 2, 2021
Dose selection for intracerebroventricular cerliponase alfa in children with CLN2 disease, translation from animal to human in a rare genetic diseaseKevin Hammon, Greg de Hart, Brian R Vuillemenot, et al.
Clinical and Translational Science|November 17, 2020
Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular AdministrationAryun Kim, Anita Grover, Kevin Hammon, et al.
Cancer Discovery|March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic CancersJohann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Pageof 1